In Vivo and Randomized Control Trial of Daruharidradi Ghanavati in Sthula Madhumeha with specific reference to Type II Diabetes Mellitus

SUSHIL VILAS CHAWRE0 个研究点目标入组 120 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1. The patients having fasting plasma sugar level more than or equal to 126mg/dl and post prandial plasma sugar level more than or equal to 200mg/dl (A.D.A 2016)
•2. The patients fulfilling criteria of diagnosis and having clinical features of Sthula Madhumeha (Diabetes Mellitus)
•3. Patients having BMI more than 23Kg/m2 up to 30Kg/m2 will be selected.
•4. HbA1c is 6.5%up to 10%.
•5. Patients having age between 30years to 70 years.
•6. Those are willing to participate in trial and ready to give their written consent.

•1. Patients who already taking anti-diabetic drugs.
•2. Patients with fasting plasma sugar level >250mg/dl and post meal plasma sugar level >350mg/dl.
•3. Patients having insulin dependent diabetes mellitus and juvenile diabetes and various other types of diabetes except Type II DM.
•4.Patients having BMI less than 23kg/m2 and More Than 30kg/m2.
•5. HbA1c more than 10%.
•6. Patients having age below 30 years and above 70 years.
•7. Patients who are currently participating in any other clinical trials since last 6 months. 8. Patients having complications such as vasculopathy, nephropathy, retinopathy and neuropathy.
•9. Patients having other systemic complications like hepatic, renal and cardiac problems.
•10. Patients having poorly controlled blood pressure.
•11. Pregnant and lactating females not included in this study.

发起方

SUSHIL VILAS CHAWRE